Johannes Jacobus Oosthuizen - 08 Feb 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, U.S. Market
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen
Issuer symbol
MRK
Transactions as of
08 Feb 2025
Net transactions value
+$575,873
Form type
4
Filing time
11 Feb 2025, 14:59:22 UTC
Previous filing
29 Jan 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $1,134,815 +13,002 +40% $87.28 45,609 08 Feb 2025 Direct
transaction MRK Common Stock Tax liability $558,941 -6,404 -14% $87.28 39,205 08 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -13,002 -100% $0.000000 0 08 Feb 2025 Common Stock 13,002 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 2/8/2025. The Reporting Person's Form 3 filed on 3/10/2022 incorrectly reported that these restricted units vested and were to be distributed in three equal installments on 2/8/2023, 2/8/2024, and 2/8/2025.